Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | CTSG | P08311 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | INMT | O95050 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19546254 | 1.00 | F2 (0.38) | F2ELANECTSGCTRCACHE | |
| SCHEMBL14423078 | 0.97 | — | — | |
| SCHEMBL16196108 | 0.87 | L3MBTL1 (0.39) | F2ELANECTSGCTRCACHE | |
| SCHEMBL15896894 | 0.87 | PIK3CD (0.35) | F2ELANECTSGCTRCACHE | |
| SCHEMBL19546266 | 0.87 | PIK3CD (0.35) | F2ELANECTSGCTRCACHE | |
| SCHEMBL19546268 | 0.87 | PIK3CD (0.35) | F2ELANECTSGCTRCACHE | |
| SCHEMBL19545972 | 0.87 | PIK3CD (0.35) | F2ELANECTSGCTRCACHE | |
| Ether SCHEMBL27741444 | 0.84 | F2 (0.32) | F2ELANECTSGCTRCLMNA | |
| SCHEMBL16196098 | 0.82 | MAPT (0.32) | MAPTPIK3CD | |
| SCHEMBL19275178 | 0.82 | CYP3A4 (0.38) | MAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160223908-A1 | PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2016-08-04 | — | — | US | claimed |
| US-9341949-B2 | Photosensitive compositions and applications thereof | PROMERUS, LLC (US) | 2016-05-17 | — | — | US | claimed |
| US-20140322647-A1 | PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF | SUMITOMO BAKELITE CO., LTD (JP) | 2014-10-30 | — | — | US | claimed |
| WO-2023242598-A1 | BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION | AMPHISTA THERAPEUTICS LIMITED (GB) | 2023-12-21 | — | — | WO | disclosed |
| US-11537045-B2 | Photosensitive compositions and applications thereof | PROMERUS, LLC (US) | 2022-12-27 | — | — | US | disclosed |
| EP-4045564-A1 | PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF | Promerus, LLC (US) | 2022-08-24 | — | — | EP | disclosed |
| CN-114555674-A | Photosensitive composition and application thereof | 普罗米鲁斯有限责任公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20210116807-A1 | PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2021-04-22 | — | — | US | disclosed |
| WO-2021076131-A1 | PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2021-04-22 | — | — | WO | disclosed |
| US-9696623-B2 | Photosensitive compositions and applications thereof | PROMERUS, LLC (US) | 2017-07-04 | — | — | US | disclosed |
| US-20160223908-A1 | PHOTOSENSITIVE COMPOSITIONS AND APPLICATIONS THEREOF | PROMERUS, LLC (US) | 2016-08-04 | — | — | US | disclosed |
| WO-2014113485-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. (US) | 2014-07-24 | — | — | WO | disclosed |
| US-20090239873-A1 | Phenyl-piperazine derivatives as modulators of muscarinic receptors | BLANCO MIGUEL GARCIA-GUZMAN | 2009-09-24 | — | — | US | disclosed |
| US-7563795-B2 | Phenyl-piperazine derivatives as modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2009-07-21 | — | — | US | disclosed |
| EP-0216745-B1 | PROCESS FOR THE PREPARATION OF N-SUBSTITUTED AMINOMETHYLPHOSPHONIC ACIDS | Monsanto Company (US) | 1991-10-16 | — | — | EP | disclosed |
| EP-0216744-B1 | THE COMPOUND 1,4-DIISOPROPYL-2,5-DIKETOPIPERAZINE | Monsanto Company (US) | 1991-08-14 | — | — | EP | disclosed |
| US-4804499-A | Process for the preparation of N-substituted aminomethylphosphonic acids | MONSANTO COMPANY (US) | 1989-02-14 | — | — | US | disclosed |
| US-4694082-A | CHEMICAL INTERMEDIATE FOR HERBICIDE | MONSANTO COMPANY (US) | 1987-09-15 | — | — | US | disclosed |
| EP-0216744-A2 | The compound 1,4-diisopropyl-2,5-diketopiperazine | Monsanto Company (US) | 1987-04-01 | — | — | EP | disclosed |
| EP-0216745-A1 | Process for the preparation of N-substituted aminomethylphosphonic acids | Monsanto Company (US) | 1987-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239873-A1 | Phenyl-piperazine derivatives as modulators of muscarinic receptors | CHRM3, CHRM5, CHRM2 | F2 4698/4885ELANE 4120/4885CTSG 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.